Related Experiment Videos
Defective cell-mediated immunity in lipoid nephrosis
International Archives of Allergy and Applied Immunology
|January 1, 1984
Summary
Lipoid nephrosis patients with nephrotic syndrome show suppressed cell-mediated immunity (CMI). This immune dysfunction may be caused by increased suppressor cell activity, impacting T lymphocyte function.
Area of Science:
- Immunology
- Nephrology
Background:
- Lipoid nephrosis (LN) is a cause of nephrotic syndrome (NS).
- The role of cell-mediated immunity (CMI) in LN pathogenesis is not fully understood.
Purpose of the Study:
- To investigate CMI status in patients with biopsy-proven lipoid nephrosis.
- To explore the potential involvement of suppressor cells in LN-associated immune dysfunction.
Main Methods:
- Assessed CMI parameters including delayed hypersensitivity skin reactivity (PPD), graft-versus-host reaction (GVHR), T lymphocyte proportion, and lymphocyte transformation (PHA).
- Measured Concanavalin A (Con A)-induced suppressor cell activity (SCA) in patients and healthy controls.
Main Results:
- LN patients with NS exhibited significantly depressed CMI and increased SCA compared to normal individuals.
- CMI and SCA levels in LN patients in remission and chronic glomerulonephritis patients were comparable to controls.
- Specific CMI deficits included impaired PPD reactivity, reduced GVHR, lower T cell counts, and diminished PHA response.
Conclusions:
- Patients with lipoid nephrosis and nephrotic syndrome display a distinct pattern of impaired cell-mediated immunity.
- Elevated suppressor cell activity is implicated in the CMI depression observed in active LN.
- These findings suggest a potential role for immunomodulatory therapies targeting suppressor cells in LN management.